Literature DB >> 33544957

Investigation of the optimal medium and application strategy for foot-and-mouth disease vaccine antigen production.

A-Y Kim1, H Kim1,2, S Y Park1, S H Park1, J-M Lee1, J-S Kim1, J-W Park1, C-K Park2, J-H Park1, Y-J Ko1.   

Abstract

AIMS: For the effective production of 146S particles, which determines foot-and-mouth disease (FMD) vaccine efficacy, we aimed to identify the optimal medium that is easy-to-use, productive and economically affordable for the large-scale production of FMD vaccine. METHODS AND
RESULTS: Nine combinations of cell growth media and replacement media were tested for virus propagation. Apart from the replacement strategy, we tested a simple addition strategy involving the addition of 30% v/v of fresh medium to the total spent medium using the Cellvento BHK-200 (Vento). Unlike other tested media that produced poor yields of 146S particles when the spent media were not eliminated, Vento exhibited high productivity with the 30% addition strategy.
CONCLUSIONS: Considering its lower price and media consumption compared to those of other media that require media replacement, the 30% addition strategy of Vento is highly effective. Furthermore, owing to its simple application strategy, it makes the scale-up process easy and helps in saving the time and labour involved in spent media removal. SIGNIFICANCE AND IMPACT OF THE STUDY: Through the first comparative assessment of commercial media for the 146S particle recovery, this study suggests the best practical medium for the industrial-scale production of FMD vaccines.
© 2021 The Society for Applied Microbiology.

Entities:  

Keywords:  bioprocessing; diseases; vaccines; veterinary; viruses

Year:  2021        PMID: 33544957     DOI: 10.1111/jam.15024

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  2 in total

1.  Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens.

Authors:  Sun Young Park; Sim-In Lee; Jong Sook Jin; Eun-Sol Kim; Jae Young Kim; Ah-Young Kim; Sang Hyun Park; Jung-Won Park; Soonyong Park; Eun Gyo Lee; Jong-Hyeon Park; Young-Joon Ko; Choi-Kyu Park
Journal:  Vaccines (Basel)       Date:  2022-06-24

2.  Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs.

Authors:  Sang-Hyun Park; Seo-Yong Lee; Jae-Seok Kim; Ah-Young Kim; Sun-Young Park; Ji-Hye Lee; Mijung Lee; Hyejin Kim; Sim-In Lee; Na-Young Kang; Jung-Won Park; Su-Mi Kim; Jong-Hyeon Park; Young-Joon Ko
Journal:  Vaccines (Basel)       Date:  2021-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.